Wells Fargo & Company »

Jasper Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Jasper Therapeutics shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Jasper Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Jasper Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jasper Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $480 609 0.79
2023-09-30 $523 749 0.70
2023-06-30 $1.1k 797 1.37
2022-12-31 $130 270 0.48
2022-09-30 $0 267 0.00
2022-06-30 $0 258 0.00
2022-03-31 $0 251 0.00
2021-12-31 $3.4k 251 13.51